Interventions to reduce kinesiophobia in breast cancer patients: a systematic review Authors: Lingqiao Gong, Panpan Xu, Xue Chen, Hong Tang, Yue Kuang Published: 2025 ABSTRACT AbstractBackgroundKinesiophobia is prevalent in breast cancer (BC) patients, often reducing physical activity and impairing rehabilitation outcomes. A systematic evaluation of interventions targeting kinesiophobia in this population is essential.ObjectiveTo assess the characteristics and efficacy of interventions for reducing kinesiophobia in BC patients.Data sourcesWe systematically searched seven databases (PubMed, CINAHL, EMBASE, Web of Science, Scopus, Cochrane Library, APA PsycInfo) for English-language studies from inception to May 2025. Eligibility criteria for selecting studiesEligible studies included Randomized controlled trials (RCTs), quasi-experimental, and pre/post designs reporting kinesiophobia-related outcomes. Methodological quality was assessed using Joanna Briggs Institute tools.ResultsEight studies (total sample size=404) evaluated seven interventions: pain neuroscience education (PNE) combined with therapeutic exercise (N=3), telerehabilitation-based relaxation (N=1), virtual reality (VR) rehabilitation (N=1), mirror therapy (MT) (N=1), complete decongestive therapy (CDT) (N=1), progressive supervised exercise (N=1), and health education (HE) (N=1). The interventions comprised 10-36 sessions delivered over 6-16 weeks, mostly therapist-delivered. Five studies were high-quality, with only two reporting non-significant effects. Preliminary evidence suggests PNE combined with therapeutic exercise, VR, MT, and progressive exercise may reduce kinesiophobia. However, the efficacy of HE alone, remotely supervised exercise, and CDT remains unclear.ConclusionOverall, the effectiveness of interventions targeting kinesiophobia in BC patients appears to be mixed, and the evidence base for each intervention remains limited. Future studies should prioritize kinesiophobia as a primary outcome and strengthen the evidence through larger sample sizes, extended follow-up periods, and high-quality RCTs.Trial registrationCRD420251060712.Supplementary InformationThe online version contains supplementary material available at 10.1186/s12905-025-04155-7.Keywords: Breast cancer, Kinesiophobia, Fear of movement, Fear-Avoidance, Rehabilitation, Virtual reality, Mirror therapy, Pain neuroscience education What is already known? ● Physical activity is crucial for breast cancer rehabilitation and prognosis, with clinical guidelines strongly recommending exercise to mitigate treatment-related adverse effects. ● Kinesiophobia is prevalent in breast cancer patients, leading to reduced physical activity and potentially impairing rehabilitation and long-term outcomes. ● Despite various interventions have been conducted in recent years to reduce kinesiophobia in breast cancer patients, no systematic review has comprehensively examined these strategies. What are the new findings? ●Based on the research objectives and variations in intervention components, the interventions were categorized into seven distinct types: pain neuroscience education combined with therapeutic exercise, telerehabilitation-based progressive relaxation exercises, virtual reality-based rehabilitation, mirror therapy, complete decongestive therapy, progressive supervised exercise, and group-based health education . ●Current research suggests that pain neuroscience education combined with therapeutic exercise, virtual reality-based rehabilitation, mirror therapy and progressive supervised exercise may effectively reduce kinesiophobia in breast cancer patients and survivors. ●It is recommended that further studies designate kinesiophobia as a primary outcome, with larger cohorts, longer follow-ups, and rigorous blinding to strengthen methodological quality. Introduction Globally, breast cancer (BC) represents a major public health concern, ranking among the primary causes of morbidity and premature mortality among women [1]. In 2022, it surpassed lung cancer to become the most prevalent diagnosed malignancy worldwide, accounting for approximately 2.30 million new cases [2]. BC treatment varies depending on diagnostic findings. Driven by advancements in surgical interventions, genetic research, pharmacological therapies, and conservative treatment approaches, the survival rates for BC have significantly improved in recent decades [1, 3]. Despite these therapeutic advances, BC patients still encounter substantial challenges throughout disease trajectory. The disease itself and treatment regimens exert profound and lasting impacts on multiple dimensions of patients’ lives, including but not limited to psychological disorders, body image, and physical functional capacity. These adverse consequences also persist among BC survivors [4–6]. Accumulating evidence [3, 7–11] indicates that regular physical activity significantly benefits cancer-related fatigue, cardiorespiratory endurance, muscular function, depressive symptoms, and quality of life in BC survivors and patients receiving chemotherapy. Moreover, sustained exercise engagement is associated with a reduced recurrence risk and lower cancer-specific mortality [12, 13]. Given these well-documented benefits, current clinical guidelines recommend integrating exercise as a fundamental component of standard cancer care, emphasizing its role as an adjunctive therapy to mitigate treatment-related adverse effects [14–16]. Despite robust evidence that physical activity is beneficial, studies consistently report a decline in exercise adherence among breast cancer patients following diagnosis [17]. The factors contributing to reduced physical activity levels in BC patients are multifactorial, with existing literature identifying key barriers including: secondary lymphedema, fatigue, insufficient guidance on permissible exercise modalities, psychological distress, and kinesiophobia (exercise-related fear) [17–21]. Kinesiophobia is defined as an excessive, irrational, and debilitating fear of physical movement and activity, due to a feeling of vulnerability to painful injury or re-injury [22]. It does not represent a psychiatric phobia in the clinical sense (i.e., it is not a DSM-5–classified anxiety disorder [23]). Instead, it is a psychological construct describing a maladaptive fear-avoidance response that leads to reduced movement and activity. According to the Fear-Avoidance Model (FAM), individuals experiencing pain or injury may develop irrational beliefs and avoidance behaviors, resulting in a self-perpetuating cycle of physical inactivity, disability, and psychological distress [24–26]. Kinesiophobia is recognized as a significant impediment to physical activity in patients with neuromuscular skeletal disorders [27]. In BC, kinesiophobia often develops due to pain, surgical trauma, lymphedema, limited shoulder mobility, fatigue, and body image disturbances, which make patients perceive movement as potentially harmful [28–30]. Emotional factors—such as fear of pain recurrence, anxiety, and reduced confidence in physical ability—may further reinforce avoidance behaviors [31, 32]. This complex interplay of physical and psychological factors explains why some patients, despite clinical stability, remain reluctant to engage in beneficial physical activity. Ultimately contributing to deteriorated prognosis and compromised quality of life in BC patients and survivors [33]. Notably, the prevalence of kinesiophobia is also at a high level in BC patients. A cross-sectional study from Turkey involving 54 BC survivors revealed a striking prevalence rate of 66.7% for kinesiophobia [34]. Elif’s [35] study revealed that approximately 70% of BC patients with secondary lymphedema developed kinesiophobia. Similarly, Gencay et al. [36]. reported that among 81 BC patients who underwent cancer-related surgery, 76% of those with kinesiophobia concurrently exhibited upper limb lymphedema. A cross-sectional study [37] conducted in Poland also demonstrated that kinesiophobia may persist in BC survivors even one year after completion of oncological treatment, with a significant negative correlation between kinesiophobia levels and physical activity engagement. Extensive research indicates that in BC populations, the fear of movement/(re)injury is typically assessed using standardized scales or questionnaires. The Tampa Scale for Kinesiophobia (TSK) [38, 39] and the Fear-Avoidance Beliefs Questionnaire (FABQ) [38] were developed in earlier years. More recently developed instruments, including the Fear-Avoidance Components Scale (FACS) [40] and the Fear of Physical Activity/Exercise Scale for Breast Cancer (FPAX-B) [41], have also been employed to evaluate kinesiophobia in BC patients. These instruments focus on the characteristics of fear and avoidance related to movement and have been widely applied in oncology populations, demonstrating satisfactory reliability and validity. Collectively, they provide an effective means of capturing movement-related fear in BC survivors. With increasing recognition of kinesiophobia as a significant health concern, targeted interventions have been implemented globally. However, research in the context of BC has emerged relatively recently and remains in its nascent stage. In recent years, several researches have conducted a series of interventional studies addressing kinesiophobia among BC patients and survivors, with preliminary efficacy. Nevertheless, existing interventions exhibit substantial heterogeneity in methodology and effectiveness, with notable limitations in systematic approach. Furthermore, a comprehensive systematic review of kinesiophobia interventions specifically for BC patients has not been identified in the current literature. Consequently, this study aims to systematically retrieve and synthesize available evidence on interventions for kinesiophobia in BC patients, with particular emphasis on intervention types and their respective efficacy outcomes. Methods This systematic review was conducted according to the revised Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols (PRISMA-P) checklist [42]. The study protocol was registered with PROSPERO (CRD420251060712). Search strategy In March 2025, and updated in May 2025, we conducted a comprehensive search across seven electronic databases: PUBMED, CINAHL, EMBASE, SCOPUS, Web of Science, Cochrane Library, and APA PsycInfo. No publication date limits were applied (coverage from database inception to May 2025). Search terms encompassed concepts related to breast cancer and kinesiophobia, incorporating both Medical Subject Headings (MeSH) and entry terms. In order to enhance completeness, the reference lists of relevant studies and reviews were screened manually, and both forward and backward citation tracking were performed for all included studies. Search strategies are detailed in Appendix 1. Study inclusion and exclusion criteria Table 1 provides an overview of the Population, Intervention, Comparison, and Outcome (PICO) framework. Studies that meet the following criteria were included in the review. Table 1Selection criteria for population intervention comparison outcome (PICO)Inclusion criteriaParticipantsPatients diagnosed with BC or BC survivorsInterventionAny intervention aimed at reducing kinesiophobia, regardless of the provider, format, content, frequency, or duration of the intervention.ControlNo restriction on comparisons, comparisons could be standard supports, active control intervention, different types of interventions, no comparator, etc.OutcomesThe study needed to report kinesiophobia as primary or secondary outcome.Study DesignEligible designs included RCTs, quasi-experimental, controlled/uncontrolled pre-/post- studies, Pilot and feasibility studies were included if intervention details and preliminary outcomes were reported.LanguageAll limited to English publications. Exclusion criteria (1) Editorials, conference abstracts, reviews, protocols, letters, comments, and articles without full-text. Selection criteria for population intervention comparison outcome (PICO) Study selection The references were imported into EndNote X9 for duplicate removal and initial screening. Study selection was independently conducted by two reviewers (LQG and PPX) in line with the predefined eligibility criteria. First, titles and abstracts were reviewed to identify studies of potential relevance. Full texts of these selected records were then retrieved and carefully examined for inclusion. Any disagreements between the two reviewers were resolved through discussion, and when consensus could not be reached, a third reviewer (XC) provided arbitration and made the final judgment. The study selection procedure is reported using the PRISMA statement flow chart [42] (see Fig. 1). PRISMA flow diagram Data extraction The data were extracted by two authors (LQG and PPX) independently, and a consensus was reached by consulting a third person (XC). The following data were extracted with the support of standardized Excel tables: Study information (name of the first author; publication year; country; design), Setting (hospital or outpatient department), Participants information (gender and age), description of the intervention (including delivery mode, facilitators, type, details, duration and frequency), control groups, outcomes and their measures, main results, and follow-up. Data extraction have been summarized in Table 2. Table 2Study characteristicsFirst Author,Country (year)DesignSettingParticipantsInterventionOutcomeHospitalOutpatientdepartment/homeNumeber(IG/CG)Age (years)(IG/CG)Mean ± SDTypesIntervention detailsTotal dose/sessionsTotal durationTotal weeksDeliverymodePersonnel delivering the supportOutcomes measurementsFollow-upResults of KinesiophobiaPatricia Martínez-Miranda, Spain(2024)[47]A single-blind randomised controlled trial✔✔N = 36 (IG = 14,CG = 22)IG(50.84 ± 8.53) CG(50.00 ± 8.04)Breast cancer survivors•Type: Pain neuroscience education (PNE) combined with therapeutic exercise (TE).•Details: Interactive online program integrating PNE, graded exposure to movement (GEM), and therapeutic yoga.•Duration and Frequency: a total of 3 months; Phase 1: 8 PNE sessions (2/week, 1 h each); Phase 2: 16 GEM-Y sessions (2/week, 1 h each).241440 min/24 h12weeksFace to face + WhatsApp and e-mailPhysiotherapistKinesiophobia: TSK-11; FACS-SPOther outcomes:• FACT-B + 4• PCS• BPI• PSEQ(T1):1 month, after PNE sessions;(T2):2months, after PNE + GEM-Yoga;(T3):3months, after 3-month follow-up.T3:•Within-group significant difference (p ≤ 0.05);•Between-group significant differences (p>0.05)Daniel Gutiérrez-Sánchez, Spain(2022)[48]A single group pre–post intervention study✔✔N = 8251.4 ± 9.3Breast cancer survivors•Type: PNE combined with TE.•Details: Patients received individualized education and exercise programs from a physiotherapist, including aerobic and strength training.•Duration and Frequency: 12 weeks, 1-hour sessions, twice weekly.241440 min/24 h12weeksFace to facePhysiotherapistKinesiophobia: FACS-SpOther outcomes:• CSI-Sp12 weeksNot significant.Jos´ e Antonio Lores-Peniche,Mexico(2024)[50]A single group pre–post intervention study✔✔N = 2656 ± 8Breast cancer survivors• Type: PNE combined with TE.• Details: PNE and therapeutic exercise.• Duration and Frequency: 9-week program; 3 PNE sessions during the first two weeks, followed by 24 TE sessions (16 in-person, 8 home-based), with in-person sessions lasting 45–60 min and home sessions 20 min each.271015-1300 min/17–21.7 h9weeksFace to face + Online platformPhysiotherapists and NursesKinesiophobia: TSK-11Other outcomes:• ROM• ULFI-Sp• VAS• DN4• CSI3rd weeks (T1)6th week (T2)9th week (T3)Significant effect (p < 0.001).Umut Bahçaci, Turkey(2024)[46]A single-center, assessor-blind, randomized controlled✔✔N = 52 (IG = 26,CG = 26)IG(49.1 ± 8.8) CG(44.7 ± 10.0)Breast cancer• Type: Telerehabilitation-based progressive relaxation exercises (PRE)• Details: Exercises targeted major joints and facial muscles, with three repetitions of 5 s contraction and 10 s relaxation. Intermittent deep inhalation and slow exhalation (three cycles) were applied.• Duration and Frequency: 40 min per session, three times weekly for six weeks via WhatsApp.18720 min/12 h6weeksWhatsAppPhysiotherapistKinesiophobia: TSK-11Other outcomes:• FIS• HAD• BPI• EORTC QLQ-C30• FACT-Cog• PSQI6 weeksNot significant (p >0.05)Özlem Feyzioğlu, Turkey(2020)[44]A prospective, randomized, controlled✔×N = 37(IG = 19,CG = 17)IG(49.21 ± 5.91) CG(51.00 ± 7.06)After breast cancer surgery•Type: Virtual reality (VR) Kinect-based rehabilitation (KBRG)•Details: Intervention included tissue massage, passive mobilization, and exercises using the Xbox 360 Kinect™ system.•Duration and Frequency: 45-minute sessions, twice weekly for six weeks.12540 min/9 h6weeksFace to facePhysiotherapistKinesiophobia: TSKOther outcomes:• VAS• Shoulder ROM• Arm strength• DASH6weeksSignificant effect(p < 0.001).Ruzhen Yuan, China, (2023)[49]A randomized controlled trial✔✔N = 79 (IG = 39,CG = 40)IG(52.68 ± 10.97) CG(54.43 ± 11.9)After breast cancer surgery•Type: Mirror therapy (MT)•Details: Participants performed active upper limb exercises using mirror therapy, including a preparation phase, warm-up, and active ROM exercises.•Duration and Frequency: 8 weeks, two sessions per week.16Not described8weeksFace to face + WeChat or phoneRehabilitation therapist and NursesKinesiophobia: TSK-13Other outcomes:• Shoulder ROM• Hand grip strength• VAS• DASH• CMS2 weeks (T1)4 weeks (T2)8 weeks (T3)T2,T3 Significant effectT1: (p>0.05)T2: (p < 0.01)T3: (p < 0.05)DIDEM KARADIBAK, Turkey,(2008)[45]A single group pre–post intervention study✔✔N = 62NoneBreast cancer• Type: Complete decongestive therapy (CDT)• Details: Included manual lymphatic drainage (MLD), skin care, compression garments and remedial exercises, with a home program of compression exercises, walking and skin care.• Duration and Frequency: 12 weeks, once per day, 1-hour sessions, three times per week.362160 min/36 h12weeksNot describedNot describedKinesiophobia: TSKOther outcomes:• FACT-B + 4• Excess volume of edema (ml, %)12 weeksSignificant effect (p < 0.00).Patricia Sheehan, Ireland,(2020)[51]Quasi-experimental study✔✔N = 30 (IG = 15,CG = 15)NoneBreast cancer survivors• Type: progressive group-based supervised exercise (EX)• Details: The EX intervention emphasised brisk walking with progressive increments, stretching, exercise education and self-efficacy enhancement.• Duration and Frequency: Ten-week program with two supervised sessions per week for the first five weeks and one session per week for the remaining five weeks, totaling 15 sessions.15Not described10weeksFace to face + calls and textsNot describedKinesiophobia:• FAPX-B10weeksExercise group changes to 16Weeks•Type: Group-based health education (HE)•Details: Focused on sleep management, nutrition, and cognitive behavioral therapy.•Duration and Frequency: 1-hour sessions, once per week for 10 weeks.10900 min/10 h10weeksNot describedNot describedNote: For other outcomes indicators, see Supplementary Data Appendix 4N Number, IG Intervention group, CG Control group, SD Standard deviation, TSK Tampa Scale for Kinesiophobia, VAS The visual analogue scale, ROM Range of motion, DASH Disabilities of the arm, shoulder and hand scale, FACS-SP Fear of Pain Avoidance Components Questionnaire—Spanish Version, FACT-B+4 Functional Evaluation for Cancer Treatment—Breast Cancer, PSEQ Pain Self-Efficacy Questionnaire, PCS Pain Catastrophizing Scale, BPI Brief Pain Inventory, FIS Fatigue Impact Scale, HAD Hospital Anxiety and Depression, EORTC QLQ-C30 The European Organization for Research and Treatment of Cancer–Quality of life, FACT-Cog Functional Assessment of Chronic Illness Therapy–Cognitive Function, CMS The Constant-Murley Score, FACS-Sp Spanish Fear Avoidance Components Scale, CSI-Sp Spanish version of the Central Sensitization Inventory, ULFI-Sp Upper Limb Functional Index Spanish adaptation, DN4 Douleur Neuropathique 4 questions, FAPX-B The Fear of Physical Activity and Exercise-Breast Cancer, PSQI Pittsburg Sleep Quality Index Study characteristics Outpatient department /home Age (years) (IG/CG) Mean ± SD Total dose/ sessions Delivery mode Patricia Martínez-Miranda, Spain (2024)[47] •Type: Pain neuroscience education (PNE) combined with therapeutic exercise (TE). •Details: Interactive online program integrating PNE, graded exposure to movement (GEM), and therapeutic yoga. •Duration and Frequency: a total of 3 months; Phase 1: 8 PNE sessions (2/week, 1 h each); Phase 2: 16 GEM-Y sessions (2/week, 1 h each). 12 weeks Kinesiophobia: TSK-11; FACS-SP Other outcomes: • FACT-B + 4 • PCS • BPI • PSEQ (T1): 1 month, after PNE sessions; (T2): 2months, after PNE + GEM-Yoga; (T3): 3months, after 3-month follow-up. T3: •Within-group significant difference (p ≤ 0.05); •Between-group significant differences (p>0.05) Daniel Gutiérrez-Sánchez, Spain (2022)[48] •Type: PNE combined with TE. •Details: Patients received individualized education and exercise programs from a physiotherapist, including aerobic and strength training. •Duration and Frequency: 12 weeks, 1-hour sessions, twice weekly. 12 weeks Kinesiophobia: FACS-Sp Other outcomes: • CSI-Sp Jos´ e Antonio Lores-Peniche, Mexico (2024)[50] • Type: PNE combined with TE. • Details: PNE and therapeutic exercise. • Duration and Frequency: 9-week program; 3 PNE sessions during the first two weeks, followed by 24 TE sessions (16 in-person, 8 home-based), with in-person sessions lasting 45–60 min and home sessions 20 min each. 1015- 1300 min /17–21.7 h Kinesiophobia: TSK-11 Other outcomes: • ROM • ULFI-Sp • VAS • DN4 • CSI 3rd weeks (T1) 6th week (T2) 9th week (T3) Umut Bahçaci, Turkey (2024)[46] • Type: Telerehabilitation-based progressive relaxation exercises (PRE) • Details: Exercises targeted major joints and facial muscles, with three repetitions of 5 s contraction and 10 s relaxation. Intermittent deep inhalation and slow exhalation (three cycles) were applied. • Duration and Frequency: 40 min per session, three times weekly for six weeks via WhatsApp. Kinesiophobia: TSK-11 Other outcomes: • FIS • HAD • BPI • EORTC QLQ-C30 • FACT-Cog • PSQI Özlem Feyzioğlu, Turkey (2020)[44] N = 37 (IG = 19,CG = 17) •Type: Virtual reality (VR) Kinect-based rehabilitation (KBRG) •Details: Intervention included tissue massage, passive mobilization, and exercises using the Xbox 360 Kinect™ system. •Duration and Frequency: 45-minute sessions, twice weekly for six weeks. Kinesiophobia: TSK Other outcomes: • VAS • Shoulder ROM • Arm strength • DASH Significant effect (p < 0.001). •Type: Mirror therapy (MT) •Details: Participants performed active upper limb exercises using mirror therapy, including a preparation phase, warm-up, and active ROM exercises. •Duration and Frequency: 8 weeks, two sessions per week. Kinesiophobia: TSK-13 Other outcomes: • Shoulder ROM • Hand grip strength • VAS • DASH • CMS 2 weeks (T1) 4 weeks (T2) 8 weeks (T3) T2,T3 Significant effect T1: (p>0.05) T2: (p < 0.01) T3: (p < 0.05) DIDEM KARADIBAK, Turkey, (2008)[45] • Type: Complete decongestive therapy (CDT) • Details: Included manual lymphatic drainage (MLD), skin care, compression garments and remedial exercises, with a home program of compression exercises, walking and skin care. • Duration and Frequency: 12 weeks, once per day, 1-hour sessions, three times per week. 12 weeks Kinesiophobia: TSK Other outcomes: • FACT-B + 4 • Excess volume of edema (ml, %) Patricia Sheehan, Ireland, (2020)[51] • Type: progressive group-based supervised exercise (EX) • Details: The EX intervention emphasised brisk walking with progressive increments, stretching, exercise education and self-efficacy enhancement. • Duration and Frequency: Ten-week program with two supervised sessions per week for the first five weeks and one session per week for the remaining five weeks, totaling 15 sessions. 10 weeks Kinesiophobia: • FAPX-B 10weeks Exercise group changes to 16Weeks •Type: Group-based health education (HE) •Details: Focused on sleep management, nutrition, and cognitive behavioral therapy. •Duration and Frequency: 1-hour sessions, once per week for 10 weeks. 10 weeks Note: For other outcomes indicators, see Supplementary Data Appendix 4 N Number, IG Intervention group, CG Control group, SD Standard deviation, TSK Tampa Scale for Kinesiophobia, VAS The visual analogue scale, ROM Range of motion, DASH Disabilities of the arm, shoulder and hand scale, FACS-SP Fear of Pain Avoidance Components Questionnaire—Spanish Version, FACT-B+4 Functional Evaluation for Cancer Treatment—Breast Cancer, PSEQ Pain Self-Efficacy Questionnaire, PCS Pain Catastrophizing Scale, BPI Brief Pain Inventory, FIS Fatigue Impact Scale, HAD Hospital Anxiety and Depression, EORTC QLQ-C30 The European Organization for Research and Treatment of Cancer–Quality of life, FACT-Cog Functional Assessment of Chronic Illness Therapy–Cognitive Function, CMS The Constant-Murley Score, FACS-Sp Spanish Fear Avoidance Components Scale, CSI-Sp Spanish version of the Central Sensitization Inventory, ULFI-Sp Upper Limb Functional Index Spanish adaptation, DN4 Douleur Neuropathique 4 questions, FAPX-B The Fear of Physical Activity and Exercise-Breast Cancer, PSQI Pittsburg Sleep Quality Index Quality assessment The quality assessment of the included studies was performed using the Critical Appraisal Tools of the Joanna Briggs Institute (JBI) [43]. Two authors (LQG and PPX) independently evaluated each study with the RCT or Quasi-Experimental Checklists; disagreements were resolved with a third author (XC). RCTs were evaluated with the 13-item RCT checklist, which examines potential bias in design, conduct, and analysis. Scores were based on the number of “yes” responses: ≤6 = low, 7–9 = moderate, ≥ 10 = high quality. Quasi-experimental and single-arm pre–post studies were assessed using the nine-item checklist with the same scoring system: ≤3 = low, 4–6 = moderate, ≥ 7 = high. No studies were excluded based on methodological quality. Data analysis Given the heterogeneity of interventions and variations of measurement tools, a meta-analysis was deemed inappropriate. Instead, the extracted data were organized and analyzed according to specific intervention types. Findings are presented narratively, with tables and figures used where appropriate to support data interpretation. Results Description of search results The initial search retrieved 2,801 records. After removing duplicates and screening titles and abstracts, 60 articles remained. An additional 5 studies were identified through citation tracking, resulting in 65 articles assessed in full text. Following this stage, 8 studies met the inclusion criteria, while 52 were excluded. Exclusion was mainly due to non-BC populations or irrelevant outcomes. The study selection process and reasons for exclusion are illustrated in the PRISMA flow diagram (Fig. 1). General information for including studies The characteristics of the included studies are summarized in Table 2. All eight articles were published between 2011 and 2024. Of these, three [44–46] originated from Turkey (37.5%), two [47, 48] from Spain(25%), one [49] from China (12.5%), one [50] from Mexico (12.5%), and one [51] from Ireland (12.5%). Regarding study design, four [44, 46, 47, 49] were RCTs (50%), three [45, 48, 50] employed a pre–post design (37.5%), and one [51] was a quasi-randomized controlled trial (12.5%). Participants and settings A total of 404 participants were enrolled in this systematic study, all of whom were female. The participants involved were BC survivors, postoperative BC patients and BC patients. The sample size for the RCT totaled 204 participants; The sample sizes of the pre–post studies ranged from 26 to 82, with a combined total of 170 participants; and the sample sizes of the quasi-randomized controlled trial were 30 participants. The mean age of the included participants ranged from 44.7 to 56 years. The studies were conducted primarily in hospital or outpatient departments, with some studies involving online interventions at home after discharge. As shown in Table 2. Interventions and effects Based on the research objectives and variations in intervention components, seven intervention methods were included in the eight studies: Pain Neuroscience Education (PNE) combined with therapeutic exercise interventions [47, 48, 50] (3/8, 37.5%), telerehabilitation-based progressive relaxation exercises (PRE) [46] (1/8, 12.5%), virtual reality (VR)-based rehabilitation intervention (1/8, 12.5%) [44], mirror therapy (MT) [49] (1/8, 12.5%), complete decongestive therapy (CDT) [45] (1/8, 12.5%), progressive group-based supervised exercise (EX) [51] (1/8, 12.5%), group-based health education programme (HE) [51] (1/8, 12.5%). The interventions comprised 10–36 sessions delivered over 6–12 weeks, with a total duration ranging from 9 to 36 h. Details are provided in Table 2. PNE combined with therapeutic exercise interventions Three studies (37.5%) evaluated the effects of PNE combined with therapeutic exercise on kinesiophobia and related outcomes. Two pre–post designs [48, 50] demonstrated significant reductions in kinesiophobia at 9 weeks (p < 0.001), whereas a RCT [47] reported significant within-group but non-significant between-group improvements over 12 weeks. In addition to mitigating kinesiophobia, these interventions also led to notable improvements in pain intensity, quality of life and upper limb function, suggesting that integrating educational and exercise components may produce broader physical and psychosocial benefits for BC patients (see Supplementary Data, Appendix 4 for details). A meta-analysis of these three studies demonstrated overall effectiveness (MD:–10.56; 95% CI:–13.61,–7.51; p < 0.01; I²= 46%) (see Appendix 2). Telerehabilitation-based progressive relaxation exercises One RCT [46] assessed a six-week tele-supervised progressive relaxation program via WhatsApp. Although between-group differences in kinesiophobia were not significant (p >0.05), the intervention notably improved pain, fatigue, sleep quality, emotional status, and quality of life, suggesting potential benefits for symptom management and health well-being during chemotherapy. VR-based intervention A RCT [44] evaluated the effectiveness of a Kinect-based virtual reality rehabilitation program compared with standard physiotherapy in postoperative BC patients. Both interventions resulted in significant within-group improvements in pain, range of motion, muscle strength, grip strength, and kinesiophobia (all p < 0.01). Notably, the VR group demonstrated a greater reduction in kinesiophobia (p < 0.001), whereas the standard physiotherapy group achieved more substantial functional gains (p < 0.05). These findings indicate that Kinect-based VR rehabilitation provides comparable physical benefits to conventional therapy, with additional advantages in reducing fear of movement through immersive engagement. Mirror therapy One RCT [49] evaluated mirror therapy in BC patients after surgery. MT was implemented by engaging the unaffected limb in functional tasks before a mirror, while the affected limb was concealed, thereby eliciting a visual illusion of movement in the impaired limb. Following discharge, individuals in the MT group were provided with instructional booklets and videos to facilitate adherence to their home-based exercise regimen, and their progress was remote monitored weekly by nurses via WeChat or telephone. Compared with controls, MT significantly reduced kinesiophobia at 4 and 8 weeks (p < 0.05) and improved shoulder flexion, abduction, functional use, and symptom relief of the affected arm at 8 weeks. Complete decongestive therapy In a study by DIDEM and colleagues [45], 62 women experiencing lymphedema following BC treatment received a 12-week course of complete decongestive therapy. The findings showed that CDT significantly decreased kinesiophobia (p < 0.000) and enhanced quality of life (p < 0.05), highlighting its effectiveness in reducing fear of activity and improving overall patient well-being. Exercise-only interventions and education-only interventions Two studies [47, 51] reported the effects of educational interventions. A quasi experimental study [51] comparing health education and progressive supervised exercise found a significant reduction in fear of physical activity (p < 0.05) in EX, but no significant change was observed in HE. The intervention had a positive impact both on EX at 9 and 26 weeks. Patricia Martínez-Miranda [47] reported non-significant results (p = 0.06) following a 4-week administration of PNE during the initial phase of the trial. We performed a meta-analysis of the pre- and post-intervention data from these two educational trials and identified no significant differences in kinesiophobia reduction (MD: −1.81; 95% CI: −10.45, 6.83; p = 0.68, I² = 0%), as shown in Appendix 3. Personnel delivering the support and delivery mode Six studies [44, 46–50] (6/8, 75%) described the personnel delivering the support, only two studies [47, 50] (2/6, 33.33%) reported the specialized training of facilitators, although the specifics of such training were not disclosed. In four studies [44, 46–48], the intervention was administered by a physical therapist (4/8, 50%); two studies [49, 50] indicated that it was offered by both a nurse and a physical therapist (2/8, 25%); and two studies [45, 51] did not specify the facilitators (2/8, 25%). Four studies [47, 49–51] (4/8, 50%) employed a combination of face-to-face and online delivery modes (including phone, online meetings, websites, and apps), two studies employed only face-to-face delivery [44, 48] (2/8, 25%), one was conducted only with an online app [46] (1/8, 12.5%), and the remaining one [45] did not disclose their delivery methods (1/8, 12.5%). Comparative approaches Comparative interventions included standardized physiotherapy [44, 49] (2/8, 25% studies), usual care [46, 47] (2/8, 25% studies), health education [51] (1/8, 12.5% study), or no intervention [45, 48, 50] (3/8, 37.5% studies). For further details, see Appendix 4. Duration of follow-up The durations of follow-up after the intervention ranged from 6 to 16 weeks, with all studies reporting follow-up data. Five included studies [44, 45, 47, 49, 50] (5/8, 62.5%) reported a significant change after interventions at their follow-up assessment. Methodological appraisal Methodological appraisal showed that three of four RCTs provided high-quality evidence [44, 46, 49] (75%), while one was at moderate risk of bias [47] (25%). In three studies [44, 46, 47] (75%), the absence of blinding for both participants and providers led to some concerns about intervention deviations, whereas one study [49] (25%) lacked blinding of providers only. Details of assessor blinding were absent in three studies [44, 46, 49], with only one [47] reporting assessor training. Intention-to-treat analysis was described in one study [47]. Details are summarized in Appendix 5. Among the three single-arm pre–post studies, two were rated moderate quality [45, 48] (66.6%) and one high quality [50] (33.3%). The absence of control groups limited causal inference. The single quasi-experimental study was rated high quality [51]. As shown in Appendix 6. Discussion To the best of our knowledge, this is the first systematic review detailing the components and effects of interventions aimed at reducing kinesiophobia in breast cancer patients, comprising eight studies: four randomized controlled trials, three before-and-after controlled trials, and one quasi-experimental study. Seven intervention methods were incorporated in the eight studies: Pain Neuroscience Education combined with therapeutic exercise interventions, telerehabilitation-based progressive relaxation exercises, virtual reality-based rehabilitation, mirror therapy, progressive group-based supervised exercise, group-based health education program, and complete decongestive therapy. The interventions in these studies differed with respect to content, delivery, frequency, duration, and setting. The effects of various interventions differed, even within studies of same type. In summary, PNE combined with therapeutic exercise had significantly greater effects on kinesiophobia (MD: −10.56; 95% CI: −13.61, −7.51; p < 0.00001, I² = 46%). Virtual reality technology and mirror therapy have also demonstrated considerable therapeutic potential. However, existing health education-only therapies or telerehabilitation may not be ideal for reducing kinesiophobia. The combination of pain neuroscience education and therapeutic exercise demonstrated significantly greater efficacy in reducing kinesiophobia and mitigating physical pain in breast cancer patients compared to alternative interventions. Furthermore, this integrated approach exhibited potential advantages in improving quality of life, pain management, and upper limb function in this patient population. These findings consistent with previous systematic review demonstrating that pain neuroscience education, whether administered in isolation or combined with exercise therapy, confers broad benefits in managing chronic pain across diverse patient populations [52–55]. While a recent review [56] focused on the efficacy of pain neuroscience education alone for managing pain among general cancer patients, our review specifically targeted breast cancer patients. All three included studies [47, 48, 50] investigated combined interventions integrating therapeutic exercise with educational approaches. Moreover, we placed particular emphasis on assessing outcomes related to kinesiophobia. In our review, two studies [47, 50] implemented pain neuroscience education for 2–3 weeks prior to introducing therapeutic exercise. However, within-group pre-post comparisons did not demonstrate superior outcomes for the combined intervention compared to PNE alone [47]. In conclusion, while the combination of therapeutic exercise and pain neuroscience education demonstrates superior efficacy over conventional therapies in reducing kinesiophobia and improving other health outcomes among BC patients, its comparative advantages over exercise therapy or PNE alone remain inconclusive. Two trials [44, 46] incorporated modern technologies: telerehabilitation-based relaxation exercises and virtual reality-based rehabilitation. In tele-rehabilitation study [46], participants in the intervention group underwent a structured tele-based rehabilitation exercise program, while the control group followed an unsupervised exercise program. Although there were no significant between-group differences in kinesiophobia, the tele-rehabilitation group demonstrated notable enhancements in cognitive function, fatigue reduction, and mood enhancement compared to control. The findings are in contrast with the experimental outcomes reported by Cil ET [57]; Ozden F [58]; Wan B-Y [59]. who reported superior efficacy of tele-rehabilitation in reducing kinesiophobia in a diverse population compared to unsupervised exercise programs. A potential explanation for this discrepancy may be the relatively low exercise adherence rate (78%) observed in our study. Previous research suggests that individuals with lower physical activity levels are more prone to developing kinesiophobia [60, 61], implying that higher exercise completion rates could lead to more substantial improvements in kinesiophobia. Furthermore, while web-based remote interventions offer numerous advantages in healthcare delivery, Karaduman’s [62] three-arm RCT demonstrated significantly greater reductions in kinesiophobia with supervised in-person rehabilitation compared to both remote and unsupervised groups. This enhanced efficacy may be attributed to the immediate feedback and correction provided by professionals, the psychological support offered through direct interaction, and the enhanced adherence and motivation fostered in a structured clinical environment. Moreover, in-person sessions allow timely detection and adjustment of improper movements, thereby improving both safety and treatment outcomes. These findings suggest that while telerehabilitation offers accessibility and convenience, its effectiveness may be limited compared to supervised programs. VR technology further enhances this approach by creating an engaging and motivational environment, thereby improving patient participation and adherence to rehabilitative exercise regimens [63]. In our study [44], participants assigned to the VR group showed higher engagement levels and reduced kinesiophobia throughout the program. Such results are consistent with the previous meta-analysis [64], which demonstrated that the integration of VR with exercise yields superior reductions in kinesiophobia compared to VR alone. The study we included examined the impact of VR on kinesiophobia in breast cancer patients, its analysis was limited to short-term (6 weeks) outcomes. Notably, a recent systematic review and meta-analysis of randomized controlled trials [65] found insufficient evidence supporting the short-term efficacy of VR in mitigating kinesiophobia, but immediate benefits were significant. Consequently, further research is warranted to strengthen and explore the potential of VR in addressing kinesiophobia among BC patients. Mirror therapy shows potential efficacy in alleviating kinesiophobia among breast cancer patients. Moreover, quantitative synthesis and meta-analysis by Hao et al. [66], revealed that MT significantly reduces pain, enhances upper extremity function, and improves quality of life in breast cancer patients. MT constitutes a component of graded motor imagery, in which the patient executes movements with the unaffected limb while observing its mirror reflection, thereby generating the illusion of bilateral symmetrical movement [67]. This visual mirror feedback may facilitate motor imagery processes and modulate cortical perceptions, ultimately contributing to pain reduction and alleviation of kinesiophobia [49]. Two clinical studies [67, 68] have demonstrated that graded motor imagery enhances shoulder function, reduces pain, and mitigates fear of movement in patients with shoulder disorders. These findings provide supportive evidence for the application of MT in breast cancer patients experiencing kinesiophobia. MT as an economical, practical and safe intervention method for managing upper limb pain and functional disorders after breast cancer surgery. Given its therapeutic potential, MT may serve as a beneficial adjunct to conventional rehabilitative exercise, thereby expanding the range of available treatment strategies for breast cancer patients. Additionally, progressive supervised exercise may alleviate kinesiophobia in breast cancer patients, as evidenced by previous studies [69, 70]. Compared to health education alone, exercise intervention demonstrates superior efficacy in mitigating kinesiophobia in BC patients [51]. However, while included research on complete decongestive therapy suggests potential benefits in reducing kinesiophobia, these findings should be interpreted cautiously. The current evidence is limited to a single-arm pre-post study with moderate methodological quality, underscoring the need for more robust, controlled investigations. Methodologically, half of the included studies (4/8, 50%) were RCTs, among which 75% (3/4) were rated as high-quality. Notably, both virtual reality and mirror therapy interventions received high-quality evaluations, reinforcing their potential efficacy in managing kinesiophobia in BC patients. PNE combined with therapeutic exercise was assessed as moderate-quality. Among the remaining studies (3/8, 37.5%), which employed single-arm pre-post designs, PNE combined with therapeutic exercise demonstrated high quality and moderate respectively, suggesting its potential applicability in this patient population. Key methodological limitations included inadequate blinding, short follow-up durations, and the absence of intention-to-treat (ITT) analyses. Furthermore, small sample sizes in multiple studies may compromise the generalizability of findings. Future research should prioritize rigorous blinding procedures, larger cohorts, ITT analysis, and extended follow-up periods to enhance validity. Strength and implications for practice To our knowledge, this is the first systematic review to comprehensively evaluate interventions aimed at reducing kinesiophobia in breast cancer patients. This review systematically categorizes existing intervention strategies, summarizes their key characteristics, and assesses their effectiveness, thereby expanding the options of clinical rehabilitation exercise methods for this population. Specifically, consideration of patients’ disease status, socioeconomic factors, and personal preferences may help inform the selection of rehabilitation exercise programs that are more acceptable and feasible in clinical practice. For example, Virtual Reality-based rehabilitation may enhance patient engagement [71]; Mirror Therapy offers a low-cost, home-based alternative [72, 73]; Pain Neuroscience Education combined with therapeutic exercise integrates cognitive and physical rehabilitation components [54]; and Progressive Supervised Exercise emphasizes structured physical guidance [74, 75]. Limitation Several limitations should be taken into account when interpreting the findings of this review. First, significant heterogeneity in the interventions across the included studies precluded a meta-analysis. Second, since most studies reported kinesiophobia as a secondary outcome, the available data were insufficient to draw robust conclusions about the efficacy of interventions in reducing kinesiophobia among breast cancer patients. Finally, certain intervention types were represented by only a single study, highlighting the need for further research with larger sample sizes, diverse populations, and more rigorous study designs to validate these findings. Implications for future research Future studies should further investigate the effect of interventions on kinesiophobia in breast cancer patients, incorporating kinesiophobia outcome as a primary intervention target and evaluating its impact as a key efficacy endpoint. Moreover, methodological rigor should be strengthened by expanding sample sizes, ensuring sufficient follow-up duration, and implementing robust blinding procedures alongside intention-to-treat (ITT) analyses. Conclusion A comprehensive search of the literature related to interventions targeting kinesiophobia in persons with breast cancer was conducted in this systematic review. The findings suggest that pain neuroscience education (PNE) combined with therapeutic exercise, virtual reality (VR) technology, mirror therapy, and progressive supervised exercise may contribute to the alleviation of kinesiophobia in breast cancer patients. These interventions exert positive effects through diverse strategies, varying delivery methods, differing durations, and distinct provider types. Future interventions could be tailored to individual patient characteristics to further alleviate exercise fear and enhance physical activity adherence. However, the efficacy of health education (HE) alone, remotely supervised rehabilitative exercise, and complete decongestive therapy (CDT) remains inconclusive. Thus, further high-quality research is warranted, including large-scale randomized controlled trials (RCTs) with diverse populations and rigorous study designs specifically addressing this issue. Supplementary Information Supplementary Material 1 Supplementary Material 2 Acknowledgements Not applicable. Provenance and peer review Not commissioned; externally peer reviewed. Abbreviations Breast cancer Fear-Avoidance Model The Tampa Scale for Kinesiophobia Fear-Avoidance Beliefs Questionnaire Fear-Avoidance Components Scale Fear of Physical Activity/Exercise Scale for Breast Cancer Randomized controlled trials Pain Neuroscience Education Progressive relaxation exercises Virtual reality Kinect-based rehabilitation Mirror therapy Complete decongestive therapy Exercise Health education Therapeutic exercise Manual lymphatic drainage Intention-to-treat Authors’ contributions Lingqiao Gong conceived the systematic review and was responsible for the planning, Conceptualization, Data curation, Formal analysis, Methodology, Software, Writing. Panpan Xu: Conceptualization, Data curation, Formal analysis, Methodology, Software. Xue Chen: Conceptualization, Supervision, Validation, Writing. Hong Tang: Conceptualization, Data curation, Software, Validation, Supervision. Yue Kuang: Conceptualization, Data curation, Methodology, Validation. All listed authors (Lingqiao Gong, Panpan Xu, Hong Tang, Yue Kuang and Xue Chen) meet the criteria for authorship, and all authors agree with the content of the manuscript. Lingqiao Gong and Panpan Xu made equal contributions to this article and are jointly listed as first authors. Funding This project was supported by grants from the Department of Health of Jilin Province(2024A042) and the Department of Education of Jilin Province (JJKH20250224KJ) to corresponding author Xue Chen. Data availability Data can be obtained from the first author(Lingqiao Gong). Declarations Ethics approval and consent for publication Not Applicable. Consent for publication Not required. Competing interests The authors declare no competing interests. Footnotes Publisher’s Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Supplementary Materials Supplementary Material 1 Supplementary Material 2 Data Availability Statement Data can be obtained from the first author(Lingqiao Gong).